Company intelligence / Profile preview

Phoster Algamar

Redondela, Galicia, Spain

Ownership: Private
Development stage: Other

Overview

Phoster Algamar is a Spanish biotechnology company focused on the research and development of bioactive compounds derived from marine macroalgae. The company leverages the biodiversity of the Atlantic coast to identify and extract high-value molecules with potential applications in the pharmaceutical, nutraceutical, and cosmetic industries. Their primary research focus involves exploring the anti-tumor and anti-inflammatory properties of seaweed-derived extracts. By combining traditional marine knowledge with modern biotechnological processes, Phoster Algamar aims to develop sustainable and natural therapeutic solutions.

Therapeutic areas: OncologyImmunology
Modalities: Small moleculeNatural products
Industry: Biotech

Drug pipeline

1 asset

Lithothamnion calcareum extract

Partnerships

Algamar

Beyond the preview

Go deeper on Phoster Algamar.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Phoster Algamar.

Explore the full profile